Vingroup launches VinSurgical to tap surgical robot market worth over $14B

Overview

Vingroup (VIC) has announced the establishment of a new subsidiary, VinSurgical, focused on surgical robots and advanced medical devices. The company has a charter capital of 300 billion VND, with Vingroup holding a 51% stake. This move expands Vingroup’s presence in high-tech healthcare, targeting the global surgical robot market valued at over $14 billion.

Key Facts

• Vingroup established VinSurgical with a charter capital of 300 billion VND, holding a 51% controlling stake.
• VinSurgical will focus on research, development, and technology transfer in surgical robots, smart medical devices, and advanced medical support solutions.
• The global surgical robot market is estimated to be worth over $14 billion.
• Vingroup already operates Vinmec, a chain of international general hospitals with JCI accreditation.
• In December 2025, Vingroup dissolved VinMedtech, a high-tech medical investment company.
• Vingroup has three other robotics subsidiaries: VinRobotic (charter capital 1,000 billion VND), VinMotion (1,000 billion VND), and VinDynamics (500 billion VND), each 51% owned by Vingroup.
• In Q1 2026, Vingroup reported consolidated net revenue of 104,352 billion VND (+24% YoY) and net profit of 5,611 billion VND (+150% YoY).

What Happened

Vingroup’s board of directors approved the establishment of VinSurgical, a new subsidiary dedicated to surgical robotics and advanced medical technology. The company will engage in research, development, and technology transfer in surgical robots, smart medical devices, and advanced medical support solutions. Vingroup will hold a 51% stake, giving it control over the new entity.

This initiative follows Vingroup’s broader strategy to expand into high-tech sectors with significant R&D intensity. The company already has a robust healthcare ecosystem, including the Vinmec hospital chain, which has achieved JCI accreditation, and partnerships with VinUni for medical training and research. Additionally, Vingroup’s AI and data units (VinBrain, VinAI, VinBigData) are integrating AI, big data, and biotechnology into healthcare.

Market Context

VIC shares closed at 221,000 VND on May 13, 2026, down 0.45% with volume of 6.456 million shares. The stock trades on HOSE. Vingroup’s Q1 2026 results showed strong growth, with revenue up 24% and net profit up 150% year-on-year, driven by industrial production and real estate. The establishment of VinSurgical signals Vingroup’s continued diversification into high-growth technology segments, which may support long-term valuation.

Strategic Significance

VinSurgical positions Vingroup to capture value in the rapidly growing surgical robot market, which is projected to exceed $14 billion globally. By leveraging its existing healthcare infrastructure (Vinmec) and AI capabilities, Vingroup can develop and deploy advanced medical technologies domestically and potentially for export. This move aligns with Vietnam’s national strategy to promote high-tech industries and reduce reliance on imported medical equipment. For long-term investors, VinSurgical represents a strategic bet on healthcare technology, a sector with high barriers to entry and strong growth potential.

What to Watch

• Progress of VinSurgical’s R&D and any partnerships with international medical technology firms.
• Integration of VinSurgical’s products into Vinmec hospitals and potential revenue contributions.
• Regulatory approvals for surgical robots in Vietnam and key export markets.
• Vingroup’s Q2 2026 earnings report for updates on subsidiary performance and capital allocation.
• Any further restructuring of Vingroup’s healthcare and robotics subsidiaries.